Weight Loss Medications
GLP-1 vs Mounjaro
Mounjaro (tirzepatide) is a dual GLP-1/GIP agonist - it works on TWO hormone pathways instead of one, often producing greater weight loss than pure GLP-1 agonists.
Traditional GLP-1s
Single hormone action (GLP-1 only)
- • Ozempic/Wegovy (semaglutide)
- • Saxenda (liraglutide)
- • 15-17% weight loss typical
Mounjaro/Zepbound
Dual hormone action (GLP-1 + GIP)
- • Tirzepatide compound
- • Enhanced metabolic effects
- • 20-25% weight loss in trials
Why Mounjaro May Be More Effective
GIP Addition
GIP (glucose-dependent insulinotropic polypeptide) adds another pathway for appetite control and metabolic improvement.
Better Glucose Control
Dual action may provide superior blood sugar management for diabetics.
Clinical Results
Head-to-head trials show tirzepatide producing 5-7% more weight loss than semaglutide at max doses.
Medical Disclaimer
All GLP-1 and GIP agonists require prescriptions. Individual results vary. Side effects are similar across the class. Work with your doctor to find the right medication.